The RESPOND Study

What is the Purpose of this Study?

This study focuses on patients at Cedars-Sinai who are suspected to have sphincter of Oddi dysfunction (SOD) or unexplained episodes of acute pancreatitis and are recommended to undergo endoscopic retrograde cholangio-pancreatography (ERCP) procedure. The purpose of the study is to examine how beneficial ERCP is for the treatment of SOD or unexplained episodes of acute pancreatitis. SOD is a disorder that involves the circular muscle that surrounds the drainage opening through which bile and pancreatic juices flow from the liver and pancreas into the duodenum (small intestine). The main procedures of the study include a standard-of-care ERCP (commonly used to treat problems in the bile ducts, and pancreas) and follow-up assessments via questionnaires to assess participants' progress and outcomes of the procedure. ERCP combines the use of X-rays and an endoscope, which is a long, flexible, lighted tube. Pain levels and use of medication will be evaluated and documented with questionnaires.


Eligibility

Not Available


Where can I participate?

Beverly


What is the full name of this clinical trial?

Results of Ercp in SPhincter of Oddi Dysfunction: The RESPOnD Study

Study Details
Disease Type/Condition

Pancreatic Diseases

Principal Investigator

Gaddam, Srinivas

Co-Investigators

Kapil Gupta, Kenneth Park, Quin Liu, Simon Lo

Age Group

Adult

Phase

Not Available

IRB Number

STUDY00000560


How do I learn more about this study?
Email
clinicaltrials@cshs.org
Study Detail
Disease Type/Condition

Pancreatic Diseases

Principal Investigator

Gaddam, Srinivas

Age Group

Adult

Phase

Not Available

IRB Number

RESPOND


Contact
Email
clinicaltrials@cshs.org